Prognostic impact of sarcopenia on immune-related adverse events in malignancies received immune checkpoint inhibitors: a systematic review and meta-analysis

BACKGROUND: Whether sarcopenia has an impact on immune-related adverse events (irAEs) in patients with malignant neoplasms receiving immune checkpoint inhibitors (ICIs) is not consistent. This study aimed to evaluate the impact of sarcopenia on all grades of irAEs. METHODS: PubMed, Embase, and Cochr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuluan, Wang, Tianyu, Lai, Wenjuan, Zhang, Mingying, Cheng, Boran, Wang, Shubin, Tong, Gangling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797877/
https://www.ncbi.nlm.nih.gov/pubmed/35116365
http://dx.doi.org/10.21037/tcr-21-1470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797877/
https://www.ncbi.nlm.nih.gov/pubmed/35116365
http://dx.doi.org/10.21037/tcr-21-1470

Ejemplares similares